2 weeks Ago By Defense World Staff
PDS Biotechnology ( NASDAQ:PDSB – Get Free Report ) is set to release its earnings data before the market opens on Thursday, November 14th. Analysts expect PDS Biotechnology to post earnings of ($0.29) per share for the quarter.
Individual interested in listening to the company’s earnings conference call can do so using this link . PDS Biotechnology ( NASDAQ:PDSB – Get Free Report ) last issued its earnings results on Tuesday, August 13th. The company reported ($0.
23) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.08.
During the same quarter in the previous year, the company posted ($0.37) earnings per share. On average, analysts expect PDS Biotechnology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
PDS Biotechnology Trading Down 8.9 % NASDAQ PDSB opened at $2.96 on Wednesday.
PDS Biotechnology has a 52-week low of $2.53 and a 52-week high of $6.85.
The firm has a 50-day moving average price of $3.25 and a 200 day moving average price of $3.29.
The stock has a market capitalization of $108.99 million, a P/E ratio of -2.66 and a beta of 1.
93. The company has a quick ratio of 3.84, a current ratio of 3.
84 and a debt-to-equity ratio of 0.45. Analyst Ratings Changes Get Our Latest Analysis on PDSB About PDS Biotechnology ( Get Free Report ) PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. Read More Five stocks we like better than PDS Biotechnology Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Is Tesla’s Valuation a Bubble or Backed by Real Growth? Why Invest in 5G? How to Invest in 5G Stocks Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for PDS Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PDS Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter .
.
